Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human MC4-R ELISA Kit (AC3231)
Cat.#: ASET-1820
Specifications
Description Human MC4-R ELISA Kit allows for the in vitro quantitative determination of human MC4-R concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.188 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.313-20 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1393 Human Synaptophysin ELISA Kit (AC2804) Quantitative inquiry ASET-2291 Human Wnt5a ELISA Kit (AC3702) Quantitative inquiry ASET-1256 Mouse Leptin ELISA Kit (AC2667) Quantitative inquiry ASET-1554 Human Neurofilament Heavy Polypeptide ELISA Kit (AC2965) Quantitative inquiry ASET-1130 Mouse Leptin ELISA Kit (AC2541) Quantitative inquiry ASET-1880 Human SOX9 ELISA Kit (AC3291) Quantitative inquiry ASET-1087 Rat Dystrophin ELISA Kit (AC2498) Quantitative inquiry ASET-2013 Mouse Neurturin ELISA Kit (AC3424) Quantitative inquiry ASET-1391 Human Laminin 2 alpha ELISA Kit (AC2802) Quantitative inquiry ASET-2107 Rat Slit2 ELISA Kit (AC3518) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket